Breeze Holdings Acquisition
NASDAQ:BREZBreeze Holdings Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to focus on businesses in the defense technology industry. The company was incorporated in 2020 and is based in Irving, Texas. Breeze Holdings Acquisition Corp operates as a subsidiary of Breeze Sponsor, LLC.
Clene
NASDAQ:CLNNClene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a completed Phase 2 platform trial to evaluate the safety and efficacy of CNM-Au8 in patients with amyotrophic lateral sclerosis (ALS); completed Phase 2 proof of concept clinical trial in patients with early symptomatic ALS; completed two open-label investigator blinded Phase 2 clinical trials on the brain's energy metabolites; completed Phase 2 clinical trial for the treatment of visual pathway deficits in chronic optic neuropathy for remyelination in stable relapsing Multiple Sclerosis; and a second Phase 2 clinical trial for the treatment of patients with Parkinson's Diseases. The company also develops CNM-AgZn17, a gel polymer suspension of silver and zinc ions that is being developed for the treatment of infectious diseases and to support wound healing; and CNM-ZnAg, a broad-spectrum antiviral and antibacterial agent to treat infection disease and to provide immune support for symptom resolution. In addition, it markets and distributes dietary supplements comprising rMetx, an aqueous zinc-silver ion dietary supplement; and KHC46, an aqueous gold dietary supplement of very low-concentration Au nanoparticles. The company is headquartered in Salt Lake City, Utah.
Longevity Acquisition
NASDAQ:LOACLongevity Acquisition Corporation does not have significant operations. The company focuses on acquiring, engaging in a share exchange, share reconstruction and amalgamation, purchasing of assets, entering into contractual arrangements, or other business combination with one or more businesses. Longevity Acquisition Corporation was founded in 2018 and is based in Shanghai, the People's Republic of China.
Roth CH Acquisition II
NASDAQ:ROCCRoth CH Acquisition II Co. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities. The company was formerly known as Roth Acquisition I Co. Roth CH Acquisition II Co. was incorporated in 2019 and is based in Newport Beach, California.
Tottenham Acquisition I
NASDAQ:TOTATottenham Acquisition I Limited does not have significant operations. The company intends to enter into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It focuses on the technology, media, telecom, education, e-commerce, health-care, and consumer goods industries with primary operations in Asia. The company was founded in 2017 and is based in Central, Hong Kong.